We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.68B
AUM Growth
+$4.27B
Cap. Flow
+$4.13B
Cap. Flow %
61.82%
Top 10 Hldgs %
13.41%
Holding
935
New
392
Increased
185
Reduced
81
Closed
253

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$84.6M
2
MCD icon
McDonald's
MCD
+$79.3M
3
BBY icon
Best Buy
BBY
+$78M
4
SPGI icon
S&P Global
SPGI
+$75.1M
5
DGX icon
Quest Diagnostics
DGX
+$73.6M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$79.1M
2
MON
Monsanto Co
MON
+$59.9M
3
TWX
Time Warner Inc
TWX
+$44M
4
ABLX
Ablynx NV
ABLX
+$38.8M
5
LBTYK icon
Liberty Global Class C
LBTYK
+$37.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.81%
2 Healthcare 17.75%
3 Technology 12.65%
4 Financials 8.92%
5 Consumer Staples 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPLK
876
DELISTED
Splunk Inc
SPLK
– –
-7,615
Closed -$749K
MRTX
877
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-8,740
Closed -$268K
GHL
878
DELISTED
Greenhill & Co., Inc.
GHL
– –
-23,906
Closed -$442K
NEWR
879
DELISTED
New Relic, Inc.
NEWR
– –
-4,900
Closed -$363K
TWNK
880
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
– –
-36,900
Closed -$546K
TRHC
881
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
– –
-7,700
Closed -$299K
RETA
882
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-10,600
Closed -$217K
VRAY
883
DELISTED
ViewRay, Inc.
VRAY
– –
-32,400
Closed -$208K
COUP
884
DELISTED
Coupa Software Incorporated
COUP
– –
-8,600
Closed -$392K
AVYA
885
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
– –
-55,260
Closed -$1.24M
ATNX
886
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-725
Closed -$247K
PRTY
887
DELISTED
Party City Holdco Inc.
PRTY
– –
-18,100
Closed -$282K
AERI
888
DELISTED
Aerie Pharmaceuticals
AERI
– –
-6,200
Closed -$336K
EXTN
889
DELISTED
Exterran Corporation
EXTN
– –
-15,400
Closed -$411K
EMWP
890
DELISTED
Eros Media World PLC
EMWP
– –
-950
Closed -$207K
EPZM
891
DELISTED
Epizyme, Inc
EPZM
– –
-64,651
Closed -$1.15M
BMTC
892
DELISTED
Bryn Mawr Bank Corp
BMTC
– –
-8,600
Closed -$378K
SBBP
893
DELISTED
Strongbridge Biopharma plc.
SBBP
– –
-37,500
Closed -$332K
FPRX
894
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-15,000
Closed -$258K
QEP
895
DELISTED
QEP RESOURCES, INC.
QEP
– –
-62,892
Closed -$616K
ADSW
896
DELISTED
Advanced Disposal Services Inc
ADSW
– –
-56,615
Closed -$1.26M
IMMU
897
DELISTED
Immunomedics Inc
IMMU
– –
-11,800
Closed -$172K
IBKC
898
DELISTED
IBERIABANK Corp
IBKC
– –
-8,207
Closed -$640K
TSG
899
DELISTED
The Stars Group Inc.
TSG
– –
-9,800
Closed -$270K
AYR
900
DELISTED
Aircastle Ltd
AYR
– –
-34,514
Closed -$685K
34 35
36
37 38

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace held 935 positions worth $6.68B, up 177% from $2.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Marshall Wace deployed $4.13B of net new capital in Q2 2018, opening 392 new positions and adding to 185 existing holdings. Its largest new stake was TSMC: 1,597,877 shares worth $58.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alibaba, an estimated $79.1M trimmed.

  • Marshall Wace's largest Q2 2018 buy was TSMC: 1,597,877 shares worth $58.4M.
  • Marshall Wace added most to Teleflex in Q2 2018, an estimated $84.6M increase.
  • Marshall Wace's biggest Q2 2018 reduction was Alibaba, cutting an estimated $79.1M.
  • Marshall Wace fully exited Monsanto Co in Q2 2018, selling an estimated $59.9M.
  • Marshall Wace's ten largest holdings make up 13% of its $6.68B portfolio in Q2 2018.
  • Marshall Wace opened 392 new positions and closed 253 in Q2 2018.
  • Marshall Wace's portfolio value rose 177% quarter-over-quarter to $6.68B.

Based on Marshall Wace's 13F filing for Q2 2018, filed 14 Aug 2018.